Mirikizumab Benefit in UC Extends Into Maintenance Phase Twice as many responders achieved clinical remission at week 40 versus placebo Jun 28, 2023
Continuing Trastuzumab After Progression Shows Promise in HER2+ Gastric/GEJ Cancer Adding anti-HER2 agent to ramucirumab, paclitaxel exceeds historical PFS with doublet Jun 28, 2023
Berry Eaters Beware: Hepatitis A May Be Lurking And a look at the bigger picture behind the frozen-food outbreaks Jun 28, 2023
Gut Microbiome Instability Associated With Lupus Nephritis Flares One specific gut microbe may be a major factor Jun 27, 2023
Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease Jun 26, 2023
Tenofovir Alafenamide Remains the Most Effective Treatment for Chronic HBV Persistent viral suppression in most patients, even after 8 years Jun 26, 2023
Can AI Help Determine if Liver Cancer Will Respond to Standard Treatment? Early model suggests a way to predict progression-free survival Jun 26, 2023
Fecal Matter Transplant Shows Promise in Cirrhosis Pilot trial demonstrates that FMT can boost gut health, prevent serious infections Jun 25, 2023
Novel Agent Leads to Fibrosis Improvement in NASH Phase IIb ENLIVEN trial saw success with various doses of pegozafermin Jun 24, 2023
Ukraine's Mobile Medical Teams Duck Rockets Public health expert describes pivot to provide medical aid in war-torn Ukraine Jun 23, 2023
Antiviral Offers 'Glimmer of Hope' in Chronic Hepatitis D At 48 weeks, bulevirtide led to undetectable HDV RNA, normalization of ALT in up to 48% Jun 23, 2023
'Game Changer' in NASH: Resmetirom Hits Endpoints in Pivotal Study Investigational drug more likely to resolve severe form of fatty liver disease, improve fibrosis Jun 22, 2023
Transfascial Mesh Fixation During Complex Hernia Repairs: To Skip or Not to Skip? No fixation was noninferior to fixation in open retromuscular ventral hernia repair, trial shows Jun 21, 2023
Inflammatory Bowel Disease Linked With Increased Stroke Risk Swedish study is largest, with longest follow-up to date Jun 14, 2023
Omitting RT Safe in Many Locally Advanced Rectal Cancers Most intermediate-risk cases can be cured without pelvic radiation, says investigator Jun 05, 2023
Neoadjuvant Chemo Flops Versus Upfront Surgery for Resectable Pancreatic Cancer Survival 13 months better with surgery, but "curiosities" in neoadjuvant arm muddy the results Jun 04, 2023
UnitedHealthcare in the Hot Seat Over GI Procedure 'Advance Notification' Policy New rule came in response to concerns over proposed prior authorization policy Jun 01, 2023
Medicaid Expansion Tied to Better Outcomes in Black Patients With GI Cancers Two-year mortality decreased for three types of GI cancer in expansion vs non-expansion states May 25, 2023
Less-Invasive Surgery for Pancreatic Cancer Proves Safe, Effective Radical resection rate noninferior to open surgery in early-stage disease, with similar survival May 25, 2023
A Close Look at the Data Backing Upadacitinib's Approval in Crohn's Compared with placebo, the JAK inhibitor improved clinical remission and endoscopic response May 25, 2023
Warning: Prior Auth for Colonoscopy Is the Wrong Way to Go The policy adds delays to care and may worsen health outcomes May 24, 2023
Anti-EGFR Rechallenge Boosts PFS in Third-Line Metastatic Colorectal Cancer ctDNA-identified wild-type tumors benefited most from adding panitumumab to standard therapy May 23, 2023
In a Reminder of AI's Limits, ChatGPT Fails Gastro Exam Both versions of the AI model failed to achieve the 70% accuracy threshold to pass May 22, 2023
Ocaliva for NASH Gets Thumbs Down From FDA Advisors Difficulty of risk mitigation for potential drug-induced liver injury weighed heavily on members May 19, 2023
First JAK Inhibitor Approved for Crohn's Disease Upadacitinib lands indication for moderately to severely active disease in adults May 18, 2023
NASH Drug Candidate Comes With 'Serious Risks,' Says FDA Staff Agency reviewers signal little support for first potential nonalcoholic steatohepatitis drug May 17, 2023
Prophylactic Antibiotics of Little Benefit in Severe Alcoholic Hepatitis Intervention reduced infections, but not mortality; no improvement on other endpoints May 10, 2023
AI in Colonoscopy: Disconnect Grows Between Academic, Community Studies Clearly helpful in manufacturers' trials, but not so much in routine practice May 09, 2023
Gut Bacteria Cocktail Helps Long COVID Oral treatment alleviates symptoms better than placebo May 09, 2023
Study: VA Surgeons Who Do Colonoscopies May Need More Training Outdone by gastroenterologists in finding adenomatous polyps May 08, 2023
Even at Stage IV, Immunotherapy Helps in Pancreatic Cancer Small but clear boost to overall survival May 07, 2023
Medicaid Expansion Seen Lifting Colon Cancer Screening for Low-Income People But not a cure-all in states boosting eligibility May 06, 2023
Statins Linked to Slower Liver Disease Progression Risk 40% lower with use among those with preexisting liver disease, study found May 04, 2023
Gut Microbiome Varies Hour to Hour, Month to Month Intraindividual shifts over time may explain why drugs don't work the same in everyone May 04, 2023
Is Unenhanced CT Accurate for Diagnosing Acute Abdominal Pain in the ED? Contrast medium may be withheld due to sensitivity, kidney disease, or lack of availability May 03, 2023
Case Shows Danger of Gallstone Ileus in Patients Over 65 Clinicians found CT scan to be best diagnostic tool May 01, 2023
Sperm Donor Banned Over Incest Fears; COVID Hampered Teen Sex; Jerry Springer Dies Health news and commentary from around the Web gathered by ΒιΆΉ΄«Γ½ staff Apr 28, 2023
FDA OKs First Poop-Based Oral Therapy Vowst approved for preventing recurrent C. difficile infections after antibiotics Apr 27, 2023
Bariatric-Metabolic Surgery More Effective Than Lifestyle Change for NASH Roux-en-Y bypass or sleeve gastrectomy resolved NASH without exacerbating liver fibrosis Apr 26, 2023
